T-cell receptor-like antibodies: Novel reagents for clinical cancer immunology and immunotherapy

Keyphrases

• Major Histocompatibility Complex 100%
• Cancer Immunotherapy 100%
• Cancer Immunology 100%
• T Cell Receptor-like Antibody 100%
• Immune Response 66%
• T Cell Receptor 66%
• MHC Class II 66%
• PMHC 66%
• Peptide Complexes 66%
• Complex Peptide 66%
• Tumor 33%
• Antigen Presentation 33%
• Antigen-specific 33%
• T Cells 33%
• Infectious Diseases 33%
• Malignant Transformation 33%
• Targeted Delivery 33%
• CD8+ 33%
• Cytotoxic T Cells 33%
• In Cancer 33%
• Viral 33%
• Viral Infection 33%
• Tumor Targeting 33%
• Major Histocompatibility Complex Molecules 33%
• Autoimmune Disease 33%
• Therapeutic Goals 33%
• Complex Interactions 33%
• Immunotherapeutics 33%
• Tumor Antigen 33%
• Peptide Antigen 33%
• Virus-infected Cell 33%
• T Cell Repertoire 33%
• Cytotoxic Drugs 33%
• Ligand Presentation 33%
• Endogeneity 33%
• Phage Display Technology 33%
• Fine Specificity 33%
• Targeting Capability 33%
• Specifity 33%

Biochemistry, Genetics and Molecular Biology

• T Cell Receptor 100%
• Major Histocompatibility Complex 100%
• Major Histocompatibility Complex Peptide 100%
• T Cell 50%
• Immune Response 50%
• Eicosanoid Receptor 25%
• Antigen Presentation 25%
• Derived Protein 25%
• Antigen Specificity 25%
• CD8 25%
• Malignant Transformation 25%
• Tumor Antigen 25%
• Phage Display 25%
• Cytotoxic T Cell 25%